Side-by-side comparison of AI visibility scores, market position, and capabilities
Largest US private cable provider with $12B revenue; broadband, Contour TV, and Cox Mobile wireless serving 5.5M customers in 18 states competing with AT&T fiber and T-Mobile fixed wireless.
Cox Communications is the largest private broadband company in the United States, providing cable TV, high-speed internet, home telephone, and home security services to approximately 5.5 million customers in 18 states — primarily serving suburban and rural markets in the South and West including Phoenix, Las Vegas, Atlanta, San Diego, and New Orleans. Owned by Cox Enterprises (the Atlanta-based family-controlled media and automotive company), Cox Communications is privately held and generates approximately $12 billion in annual revenue from its telecommunications services.\n\nCox's product portfolio centers on Gigablast and Panoramic WiFi broadband internet (offering up to 2 Gbps speeds through its upgraded hybrid fiber-coaxial network), Contour TV (cable television with voice-remote and cloud DVR), Cox Mobile (wireless service using Verizon's network as an MVNO), and Cox Homelife (home security and automation). The company has invested heavily in network upgrades, deploying DOCSIS 3.1 technology to provide multi-gigabit internet access across its footprint.\n\nIn 2025, Cox faces the structural challenges affecting all cable operators: cord-cutting (customers cancelling cable TV for streaming services), broadband competition from AT&T and other fiber overbuilders entering Cox markets, and potential competition from fixed wireless access from T-Mobile and Verizon. Cox Mobile (launched 2021) is growing as a cable operator wireless bundle that competes with Comcast's Xfinity Mobile and Charter's Spectrum Mobile using MVNO arrangements. Cox's 2025 strategy focuses on broadband network upgrades (multi-gig speeds and fiber deep deployments), growing Cox Mobile subscriber base, and managing the TV subscriber decline while growing broadband revenue per customer.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.